login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ACLARION INC -CW27 (ACONW) Stock News
USA
-
Nasdaq
- NASDAQ:ACONW -
0.04
USD
+0 (+0.5%)
Last: 11/25/2025, 8:23:59 PM
Overview
Stock Chart
Technical Analysis
News
ACONW Latest News, Press Relases and Analysis
All
Press Releases
25 days ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion
a month ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
2 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst
2 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference
2 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
3 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Appoints Greg Gould as Chief Financial Officer
7 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Welcomes Advocate Health as CLARITY Trial Site
8 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Announces Reverse Stock Split
2 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Presents at LSI Europe ’25 Highlighting Nociscan Technology and Key Value Drivers
2 months ago - By: Aclarion, Inc.
- Mentions:
ACON
First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial
4 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts
5 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders
5 months ago - By: Aclarion, Inc.
- Mentions:
ACON
First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial
5 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum
9 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Provides Shareholder Update
a year ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash
a year ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
6 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site
6 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site
7 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Announces Texas Back Institute as New CLARITY Trial Site
7 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Announces Commercial Agreement with Spine Institute of Louisiana
7 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025
7 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis
a year ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
a year ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
a year ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Announces First Commercial Agreement in Michigan
8 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub
8 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California
9 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey
9 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Announces First Commercial Agreement with Scripps Health
9 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
9 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit
10 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body
10 months ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
a year ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
a year ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
a year ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation Market
a year ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
a year ago - By: Aclarion, Inc.
- Mentions:
ACON
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans
Please enable JavaScript to continue using this application.